| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.099 | 0.05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.088 | 0.09 |